IL92796A0 - Antiretroviral furan ketones - Google Patents

Antiretroviral furan ketones

Info

Publication number
IL92796A0
IL92796A0 IL92796A IL9279689A IL92796A0 IL 92796 A0 IL92796 A0 IL 92796A0 IL 92796 A IL92796 A IL 92796A IL 9279689 A IL9279689 A IL 9279689A IL 92796 A0 IL92796 A0 IL 92796A0
Authority
IL
Israel
Prior art keywords
antiretroviral
furan
ketones
furan ketones
antiretroviral furan
Prior art date
Application number
IL92796A
Other languages
English (en)
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of IL92796A0 publication Critical patent/IL92796A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/58One oxygen atom, e.g. butenolide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40Radicals substituted by oxygen atoms
    • C07D307/46Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/64Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
IL92796A 1988-12-21 1989-12-19 Antiretroviral furan ketones IL92796A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28776288A 1988-12-21 1988-12-21

Publications (1)

Publication Number Publication Date
IL92796A0 true IL92796A0 (en) 1990-09-17

Family

ID=23104228

Family Applications (1)

Application Number Title Priority Date Filing Date
IL92796A IL92796A0 (en) 1988-12-21 1989-12-19 Antiretroviral furan ketones

Country Status (15)

Country Link
EP (1) EP0374886A3 (no)
JP (1) JPH02221269A (no)
KR (1) KR900009620A (no)
CN (1) CN1043711A (no)
AU (1) AU621434B2 (no)
CA (1) CA2005991A1 (no)
DK (1) DK650089A (no)
FI (1) FI896134A0 (no)
HU (1) HUT52492A (no)
IL (1) IL92796A0 (no)
NO (1) NO895158L (no)
NZ (1) NZ231856A (no)
PH (1) PH26687A (no)
PT (1) PT92633A (no)
ZA (1) ZA899742B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ231857A (en) * 1988-12-21 1991-10-25 Merrell Dow Pharma Furan ketone derivatives and antiretroviral compositions
US5759791A (en) * 1989-01-17 1998-06-02 The Johns Hopkins University Cancer related antigen
US5759837A (en) * 1989-01-17 1998-06-02 John Hopkins University Chemotherapy for cancer by inhibiting the fatty acid biosynthetic pathway
US5665874A (en) * 1989-01-17 1997-09-09 John Hopkins University Cancer related antigen
US5614551A (en) * 1994-01-24 1997-03-25 The Johns Hopkins University Inhibitors of fatty acid synthesis as antimicrobial agents
US5981575A (en) * 1996-11-15 1999-11-09 Johns Hopkins University, The Inhibition of fatty acid synthase as a means to reduce adipocyte mass
CN100395241C (zh) * 2006-05-26 2008-06-18 中国科学院南海海洋研究所 一种降解呋喃二倍半萜角质海绵素及其制备方法和应用
AU2008287542C1 (en) * 2007-06-01 2015-01-22 The Trustees Of Princeton University Treatment of viral infections by modulation of host cell metabolic pathways
ES2481346B1 (es) * 2012-12-26 2015-05-08 Consejo Superior De Investigaciones Científicas (Csic) Procedimiento de obtención de moléculas orgánicas útiles como nuevos agentes surfactantes.
CN114163407B (zh) * 2020-09-11 2023-10-24 中国科学院宁波材料技术与工程研究所 抑制或杀灭微生物的呋喃环类成分、含其的制品及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1104574A (en) * 1976-12-20 1981-07-07 Roger A. Parker Antirhinovirus agents
FR2518999A1 (fr) * 1981-12-28 1983-07-01 Agrifurane Sa Procede de preparation de composes cetoniques en particulier de composes furanniques ou composes cetoniques a longues chaines, composes furanniques et composes cetoniques a longues chaines prepares par mise en oeuvre dudit procede
US4801698A (en) * 1986-08-15 1989-01-31 Warner-Lambert Company Process for preparing diaminopyrimido(4,5-d)pyrimidine glycoside and glycotide
NZ231857A (en) * 1988-12-21 1991-10-25 Merrell Dow Pharma Furan ketone derivatives and antiretroviral compositions

Also Published As

Publication number Publication date
HUT52492A (en) 1990-07-28
AU621434B2 (en) 1992-03-12
HU896706D0 (en) 1990-02-28
CA2005991A1 (en) 1990-06-21
FI896134A0 (fi) 1989-12-20
EP0374886A2 (en) 1990-06-27
JPH02221269A (ja) 1990-09-04
DK650089D0 (da) 1989-12-20
PT92633A (pt) 1990-06-29
ZA899742B (en) 1990-09-26
EP0374886A3 (en) 1992-01-02
KR900009620A (ko) 1990-07-05
NO895158L (no) 1990-06-22
NO895158D0 (no) 1989-12-20
DK650089A (da) 1990-06-22
PH26687A (en) 1992-09-15
AU4693089A (en) 1990-06-28
NZ231856A (en) 1991-05-28
CN1043711A (zh) 1990-07-11

Similar Documents

Publication Publication Date Title
GB2224159B (en) Resonator
EP0328056A3 (en) Muffler
ZW8689A1 (en) Furan derivatives
EP0394451A4 (en) Muffler
IL92796A0 (en) Antiretroviral furan ketones
ZA892803B (en) Propanamine derivatives
IL89997A0 (en) Propanamine derivatives
GB8401149D0 (en) Furanone derivatives
GB2236498B (en) Continuous casting
GB8817075D0 (en) Oscillation suppressor
IE894112L (en) Antiretroivral furan ketones
GB8811060D0 (en) Substituted ketones
ZA895418B (en) Furan derivatives
GB8803206D0 (en) Selected heterocyclic ketones
GB8718432D0 (en) Substituted ketones
CA60766S (en) Spoon
IE882489L (en) Benzofurans
IE880935L (en) Furan derivatives
CS8805197A2 (en) Self-hardening suspension
IE881707L (en) Furanones
AU102062S (en) Spoon
AU102100S (en) Spoon
IE861740L (en) Furanone derivatives
ZA89645B (en) Isoquinolinones
IE880253L (en) Bridge

Legal Events

Date Code Title Description
HC Change of name of proprietor(s)

Owner name: AVENTIS INC.

Free format text: FORMER NAME:MERRELL PHARMACEUTICALS INC.